<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-90188" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hemorrhagic Stroke</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Unnithan</surname>
            <given-names>Ajaya Kumar A.</given-names>
          </name>
          <aff>Muthoot Hospital, Kozhencherry</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Das</surname>
            <given-names>Joe M.</given-names>
          </name>
          <aff>Imperial College Healthcare NHS Trust, London</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mehta</surname>
            <given-names>Parth</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ajaya Kumar Unnithan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Joe Das declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Parth Mehta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-90188.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hemorrhagic stroke is due to bleeding into the brain by the rupture of a blood vessel. Hemorrhagic stroke may be further subdivided into intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). Hemorrhagic stroke is associated with severe morbidity and high mortality. Progression of hemorrhagic stroke is associated with worse outcomes. Early diagnosis and treatment are essential given the usual rapid expansion of hemorrhage, causing sudden deterioration of consciousness and neurological dysfunction. This activity highlights the role of the interprofessional team in the evaluation and treatment of hemorrhagic stroke.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Summarize the pathophysiology of hemorrhagic stroke.</p></list-item><list-item><p>Identify the most common causes of hemorrhagic stroke and the most common site of the bleeding.</p></list-item><list-item><p>Review the common presentations of this hemorrhagic stroke.</p></list-item><list-item><p>CT scan is the initial investigation of choice. Prompt medical, sometimes surgical (in indicated cases), management is needed for recovery from hemorrhagic stroke.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=90188&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=90188">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-90188.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><bold>Cerebrovascular accident (CVA)</bold>, otherwise called a stroke, is the third major cause of morbidity and mortality in many developed countries. Stroke can be either ischemic or hemorrhagic. Ischemic stroke is due to the loss of blood supply to an area of the brain. It is a common type of stroke.</p>
        <p><bold>Hemorrhagic stroke</bold> is due to bleeding into the brain by the rupture of a blood vessel. Hemorrhagic stroke may be further subdivided into intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). ICH is bleeding into the brain parenchyma, and SAH is bleeding into the subarachnoid space. Hemorrhagic stroke is associated with severe morbidity and high mortality.<xref ref-type="bibr" rid="article-90188.r1">[1]</xref> Progression of hemorrhagic stroke is associated with worse outcomes. Early diagnosis and treatment are essential given the usual rapid expansion of hemorrhage, causing sudden deterioration of consciousness and neurological dysfunction.</p>
      </sec>
      <sec id="article-90188.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><bold>Hypertension</bold> is the most common cause of hemorrhagic stroke.<xref ref-type="bibr" rid="article-90188.r2">[2]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Longstanding hypertension produces degeneration of media, breakage of the elastic lamina, and fragmentation of smooth muscles of arteries.</p>
          </list-item>
          <list-item>
            <p>Lipohyalinosis, fibrinoid necrosis of the subendothelium, microaneurysms, and focal dilatations are seen in the arterioles.&#x000a0;The microaneurysms are named as Charcot-Bouchard aneurysms.</p>
          </list-item>
          <list-item>
            <p>The common sites of hypertension-induced intracerebral hemorrhage are the small penetrating arteries originating from basilar arteries or the anterior, middle, or posterior cerebral arteries.</p>
          </list-item>
          <list-item>
            <p>Small artery branches of 50&#x000a0;to 700 &#x003bc;m in diameter often have multiple sites of rupture associated with layers of platelet and fibrin aggregates.</p>
          </list-item>
          <list-item>
            <p>Hypertensive change causes non-lobar intracranial hemorrhage (ICH). As seen in eclampsia, acute hypertension can also cause ICH, known as postpartum ICH.</p>
          </list-item>
        </list>
        <p><bold>Cerebral amyloid angiopathy (CAA)</bold>&#x000a0;is an important cause of&#x000a0;primary lobar intracerebral bleeding in older adults.<xref ref-type="bibr" rid="article-90188.r3">[3]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>It is characterized by the&#x000a0;deposition of the amyloid-&#x003b2; peptide in the capillaries, arterioles, and small- and medium-sized arteries in the cerebral cortex, leptomeninges, and cerebellum.</p>
          </list-item>
          <list-item>
            <p>This causes ICH in older adults, commonly associated with variations in the gene encoding apolipoprotein E.</p>
          </list-item>
          <list-item>
            <p>A&#x000a0;familial syndrome can occur in young patients, typically associated with mutations in the gene encoding amyloid precursor protein.</p>
          </list-item>
          <list-item>
            <p>The incidence of CAA increases with age to the extent that around 50% of those aged more than 70years have CAA. Recurrent hemorrhages can occur due to CAA.</p>
          </list-item>
        </list>
        <p>
<bold>Other Important Risk Factors</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Cigarette smoking and moderate or heavy alcohol consumption, and chronic alcoholism are significant risk factors.</p>
          </list-item>
          <list-item>
            <p>Chronic liver disease also increases the chance of ICH due to coagulopathy and thrombocytopenia.</p>
          </list-item>
          <list-item>
            <p>Decreased low-density lipoprotein cholesterol and low triglycerides&#x000a0;are also risk factors.</p>
          </list-item>
          <list-item>
            <p>Dual antiplatelet therapy has an increased risk of ICH than monotherapy.</p>
          </list-item>
          <list-item>
            <p>Sympathomimetics such as cocaine, heroin, amphetamine, ephedrine, and phenylpropanolamine&#x000a0;carry an increased risk of a cerebral hemorrhage.</p>
          </list-item>
          <list-item>
            <p>Cerebral microbleeds (CMBs) associated with hypertension, diabetes mellitus, and cigarette smoking increase the risk of ICH.</p>
          </list-item>
          <list-item>
            <p>Old&#x000a0;age and male sex. The incidence of ICH increases after 55 years of age. The relative risk after 70 years is 7.</p>
          </list-item>
          <list-item>
            <p>The tumors&#x000a0;which are more prone&#x000a0;to&#x000a0;bleed are glioblastoma, lymphoma, metastasis, meningioma, pituitary adenoma, and hemangioblastoma.&#x000a0;</p>
          </list-item>
        </list>
        <p>The usual causes of spontaneous subarachnoid hemorrhage (SAH) are ruptured aneurysm, arteriovenous malformation, vasculitis, cerebral artery dissection, dural sinus thrombosis, and pituitary apoplexy. The risk factors are hypertension, oral contraceptive pills, substance abuse, and pregnancy.&#x000a0;</p>
        <p>Intracranial hemorrhage of pregnancy (ICHOP-intracerebral or subarachnoid hemorrhage) occurs with eclampsia. It is due to the loss of cerebrovascular autoregulation.</p>
      </sec>
      <sec id="article-90188.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Hemorrhagic stroke contributes to 10% to 20% of strokes annually.<xref ref-type="bibr" rid="article-90188.r4">[4]</xref><xref ref-type="bibr" rid="article-90188.r1">[1]</xref><xref ref-type="bibr" rid="article-90188.r5">[5]</xref> The percentage of hemorrhage in stroke is 8-15% in the United States of America, the United Kingdom, and Australia, and 18% to 24% in Japan and Korea. The incidence is around 12% to 15% of cases per 1,00,000 per year. The incidence is high in low and middle-income countries and Asians. The incidence is more common in men and increases with age. The global incidence is increasing, predominantly in African and Asian countries. Japanese data have shown that control of hypertension reduces the incidence of ICH. The case fatality rate is 25% to 30% in high-income countries, while it is 30% to 48% in low- to middle-income countries. The ICH fatality rate depends on the efficacy of critical care.</p>
      </sec>
      <sec id="article-90188.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The common sites of the bleed are the basal ganglia (50%), cerebral lobes (10% to 20%), the thalamus (15%), pons and the brain stem (10% to 20%), and the cerebellum(10%)(fig.1,2,3).<xref ref-type="bibr" rid="article-90188.r1">[1]</xref> The hematoma disrupts the neurons and glia. This results in oligaemia, neuro-transmitter release, mitochondrial dysfunction, and cellular swelling. Thrombin activates microglia and causes inflammation and edema.<xref ref-type="bibr" rid="article-90188.r5">[5]</xref><xref ref-type="bibr" rid="article-90188.r6">[6]</xref></p>
        <p>The primary injury is due to the compression of brain tissue by the hematoma and an increase in the intracranial pressure(ICP).<xref ref-type="bibr" rid="article-90188.r7">[7]</xref></p>
        <p>Secondary injury is contributed to by inflammation, disruption of the blood-brain barrier (BBB), edema, overproduction of free radicals such as reactive oxygen species (ROS), glutamate-induced excitotoxicity, and release of hemoglobin and iron from the clot.</p>
        <p>Usually, the hematoma enlarges in 3 hours to 12 hours. The enlargement of hematoma occurs in 3 hours in one-third of cases. The perihematomal edema increases within 24 hours, peaks around 5&#x000a0;to 6 days, and lasts up to 14 days. There is an area of hypoperfusion around the hematoma. The factors causing deterioration in ICH are an expansion of hematoma, intraventricular hemorrhage, perihematomal edema, and inflammation.<xref ref-type="bibr" rid="article-90188.r1">[1]</xref> Cerebellar hematoma produces hydrocephalus by compression of the fourth ventricle in the early stage.</p>
        <p>Non-aneurysmal spontaneous subarachnoid hemorrhage may be either perimesencephalic or non-perimesencephalic SAH. In perimesencephalic SAH, bleeding is mainly in the interpeduncular cistern. Physical exertion, such as the Valsalva maneuver producing increased intrathoracic pressure, and elevated intracranial venous pressure, is a predisposing factor for perimesencephalic nonaneurysmal SAH (PM-SAH).<xref ref-type="bibr" rid="article-90188.r8">[8]</xref> There is diffuse blood distribution&#x000a0;in non-perimesencephalic SAH (NPM-SAH).<xref ref-type="bibr" rid="article-90188.r9">[9]</xref></p>
      </sec>
      <sec id="article-90188.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The common presentations of stroke are headache, aphasia, hemiparesis, and facial palsy.<xref ref-type="bibr" rid="article-90188.r10">[10]</xref>&#x000a0;The presentation of hemorrhagic stroke is usually acute and progressing. Acute onset headache, vomiting, neck stiffness, increases in blood pressure, and the rapidly developing neurological signs are the common clinical manifestations of hemorrhagic stroke.<xref ref-type="bibr" rid="article-90188.r5">[5]</xref>&#x000a0;Symptoms can lead to the extent and location of hemorrhage.</p>
        <list list-type="bullet">
          <list-item>
            <p>Headache is more common in a large hematoma.</p>
          </list-item>
          <list-item>
            <p>Vomiting indicates raised intracranial pressure and is common with cerebellar hematoma.</p>
          </list-item>
          <list-item>
            <p>Coma occurs in the involvement of the reticular activating system of the brainstem.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Seizure, aphasia, and hemianopia are seen in lobar hemorrhage.&#x000a0;A prodrome consisting of numbness, tingling, and weakness may also occur in lobar bleed.</p>
          </list-item>
          <list-item>
            <p>Contralateral sensorimotor deficits are the features in hemorrhage of the basal ganglia and thalamus.</p>
          </list-item>
          <list-item>
            <p>Loss of all sensory modalities is the main feature of thalamic hemorrhage.</p>
          </list-item>
          <list-item>
            <p>Extension of thalamic hematoma into the midbrain can cause vertical gaze palsy, ptosis, and unreactive pupil.</p>
          </list-item>
          <list-item>
            <p>Cranial nerve dysfunction with contralateral weakness indicates brainstem hematoma.<xref ref-type="bibr" rid="article-90188.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Usually, pontine hematoma produces coma and quadriparesis.<xref ref-type="bibr" rid="article-90188.r11">[11]</xref></p>
          </list-item>
        </list>
        <p>Cerebellar hemorrhage produces symptoms of raised ICP, such as lethargy, vomiting, and bradycardia. Progressive neurological deterioration indicates the enlargement of hematoma or an increase in edema.</p>
        <p>The clinical features of subarachnoid hemorrhage are severe headache described as a thunderclap, vomiting, syncope, photophobia, nuchal rigidity, seizures,&#x000a0;and decreased level of consciousness.<xref ref-type="bibr" rid="article-90188.r8">[8]</xref><xref ref-type="bibr" rid="article-90188.r9">[9]</xref> Signs of meningismus such as the Kernig sign (pain on straightening the knee when the thigh is flexed to 90 degrees) and Brudzinski sign (involuntary hip flexion on flexing the neck of the patient) may be positive.</p>
      </sec>
      <sec id="article-90188.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Computerized tomography (CT) is usually the initial investigation.<xref ref-type="bibr" rid="article-90188.r12">[12]</xref>&#x000a0;The hemorrhage increases in attenuation from 30-60 Hounsfield units (HU) in the hyperacute phase to 80&#x000a0;to 100 HU over hours.<xref ref-type="bibr" rid="article-90188.r13">[13]</xref>&#x000a0;The attenuation may be decreased in anemia and coagulopathy. Vasogenic edema around the hematoma may increase for up to 2 weeks.&#x000a0;CT is considered the &#x0201c;gold standard&#x0201d; in detecting acute hemorrhage due to its sensitivity. However, gradient echo and T2* susceptibility-weighted&#x000a0;magnetic resonance imaging&#x000a0;(MRI) has the same sensitivity as CT to detect acute hemorrhage. These sequences are more sensitive than CT for identification of prior hemorrhage.</p>
        <p>In the subacute phase, the hematoma may be isodense to brain tissue, and magnetic resonance imaging (MRI) may be necessary. The volume of the hematoma can be measured by the formula AxBxC/2, where A and B are the largest diameter and the diameter perpendicular to that.<xref ref-type="bibr" rid="article-90188.r14">[14]</xref>&#x000a0;C is the vertical height of the hematoma. Intracerebral hemorrhage with a volume of more than 60 ml is associated with high mortality.<xref ref-type="bibr" rid="article-90188.r15">[15]</xref>&#x000a0;The other poor prognostic factors are hematoma expansion, intraventricular hemorrhage, infra-tentorial location, and contrast extravasation on CT scan (spot sign).<xref ref-type="bibr" rid="article-90188.r5">[5]</xref>&#x000a0;The paramagnetic properties of deoxyhemoglobin allow early detection of hemorrhage in MRI.<xref ref-type="bibr" rid="article-90188.r16">[16]</xref>&#x000a0;Gradient echo (GRE) imaging is as good as CT in detecting acute bleed. MRI can distinguish between the hemorrhagic transformation of infarct and primary hemorrhage. MRI can detect underlying causes of secondary hemorrhages, such as vascular malformations, including cavernomas, tumors, and cerebral vein thrombosis.</p>
        <p>Extravasation of contrast in CT angiogram (CTA) indicates ongoing bleeding associated with fatality.<xref ref-type="bibr" rid="article-90188.r17">[17]</xref>&#x000a0;Multidetector CT angiography(MDCTA) helps rule out the causes of secondary hemorrhagic stroke such as arteriovenous malformation (AVM), ruptured aneurysm, dural venous sinus (or cerebral vein) thrombosis (DVST/CVT), vasculitis, and Moya-Moya disease.<xref ref-type="bibr" rid="article-90188.r18">[18]</xref> (fig.4).</p>
        <p>Certain imaging characteristics help in the differentiation of the underlying disease.<xref ref-type="bibr" rid="article-90188.r19">[19]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Multiple hemorrhages of different ages in parieto-occipital lobes are seen in cerebral amyloid antipathy.</p>
          </list-item>
          <list-item>
            <p>Hemorrhage in an arterial territory indicates hemorrhagic infarction.</p>
          </list-item>
          <list-item>
            <p>Multiple stages of bleed in the same hematoma with a fluid level are seen in anticoagulation-induced hemorrhages.</p>
          </list-item>
          <list-item>
            <p>A combination of small ischemic and hemorrhagic lesions indicates vasculitis.</p>
          </list-item>
          <list-item>
            <p>Hemorrhage in the presence of occlusion of arteries is the feature of Moyamoya disease.</p>
          </list-item>
        </list>
        <p>Four-vessel digital subtraction angiography (DSA) is necessary in the case of SAH. A repeat study is needed to confirm if the DSA is negative for an aneurysm. Repeat angiography is advisable at 1-week and 6-weeks intervals.</p>
        <p>Vascular abnormalities need to be suspected if the following findings are present on a plain CT scan:</p>
        <list list-type="bullet">
          <list-item>
            <p>Subarachnoid&#x000a0;hemorrhage</p>
          </list-item>
          <list-item>
            <p>Enlarged vessels or calcifications along the margins of the ICH</p>
          </list-item>
          <list-item>
            <p>Hyperattenuation within a dural venous sinus</p>
          </list-item>
          <list-item>
            <p>A cortical vein along the presumed venous drainage path</p>
          </list-item>
          <list-item>
            <p>Unusual hematoma shape</p>
          </list-item>
          <list-item>
            <p>Presence of edema out of proportion to the time of presumed ICH</p>
          </list-item>
          <list-item>
            <p>An unusual hemorrhage location</p>
          </list-item>
          <list-item>
            <p>Presence of other abnormal structures in the brain (like a mass)<xref ref-type="bibr" rid="article-90188.r20">[20]</xref><xref ref-type="bibr" rid="article-90188.r21">[21]</xref></p>
          </list-item>
        </list>
        <p>An additional MRI scan will be beneficial in the following circumstances to identify a secondary cause for ICH:</p>
        <list list-type="bullet">
          <list-item>
            <p>Lobar hemorrhage location</p>
          </list-item>
          <list-item>
            <p>Age &#x0003c;55 years, and</p>
          </list-item>
          <list-item>
            <p>No history of hypertension</p>
          </list-item>
        </list>
        <p>Magnetic resonance venography or CT venography is indicated&#x000a0;based on the following conditions that suggest cerebral venous thrombosis:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hemorrhage location</p>
          </list-item>
          <list-item>
            <p>Relative edema volume</p>
          </list-item>
          <list-item>
            <p>Abnormal signal in the cerebral sinuses</p>
          </list-item>
        </list>
        <p>Blood investigations such as bleeding time, clotting time, platelet count, peripheral smear, prothrombin time (PT), and activated partial thromboplastin time(aPTT) will detect any abnormality of bleeding or coagulation and any hematological disorder which can cause hemorrhage. Liver function tests and renal function tests are also needed to exclude any hepatic or renal dysfunction as a cause. The investigations to rule out vasculitis are the quantitative evaluation of immunoglobulins, thyroid antibodies, rheumatoid factor, antinuclear antibodies (ANA), anti-double-stranded DNA (ds-DNA antibodies), Histon antibodies, complement, anti-Ro [SS-A] and anti-La [SS-B-] antibodies, cytoplasmic staining and perinuclear staining antineutrophil cytoplasmic antibodies (c- and pANCA), and anti-endothelial antibodies.<xref ref-type="bibr" rid="article-90188.r22">[22]</xref></p>
      </sec>
      <sec id="article-90188.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There are many different opinions on the treatment&#x000a0;of hemorrhagic stroke. There are many trials&#x000a0;on the optimal management of hemorrhagic stroke - Antihypertensive Treatment in Acute Cerebral Hemorrhage(ATACH), Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT), Factor VIIa for Acute Hemorrhagic Stroke Treatment (FAST), and Surgical Trial in Intracerebral Haemorrhage (STICH).<xref ref-type="bibr" rid="article-90188.r23">[23]</xref> The role of surgery in hemorrhagic stroke is a controversial topic.</p>
        <p>
<bold>Blood pressure (BP) Management</bold>
</p>
        <p>BP should be reduced gradually to 150/90 mmHg using beta-blockers (labetalol, esmolol), ACE inhibitor (enalapril), calcium channel blocker (nicardipine), or hydralazine.<xref ref-type="bibr" rid="article-90188.r4">[4]</xref> BP should be checked every 10-15 minutes. ATACH study observed a nonsignificant relationship between the magnitude of systolic blood pressure (SBP) reduction and hematoma expansion and 3-month outcome.<xref ref-type="bibr" rid="article-90188.r24">[24]</xref>&#x000a0;But the INTERACT study showed that early intensive BP-lowering treatment attenuated hematoma growth over 72 hours.<xref ref-type="bibr" rid="article-90188.r25">[25]</xref> It has been found that high SBP is associated with neurological deterioration and death.<xref ref-type="bibr" rid="article-90188.r20">[20]</xref>&#x000a0;The American Stroke Association (ASA) recommendation is that for patients presenting with SBP between 150 and 220 mmHg, the acute lowering of SBP to 140 mmHg is safe&#x000a0;and can improve functional outcomes. For patients presenting with SBP &#x0003e;220 mmHg, an aggressive reduction of BP with a continuous intravenous infusion&#x000a0;is needed.</p>
        <p>
<bold>Management of Raised Intracranial Pressure (ICP)</bold>
</p>
        <p>The initial treatment for raised ICP is elevating the head of the bed to 30 degrees and using osmotic agents (mannitol, hypertonic saline). Mannitol 20% is given at a dose of 1.0&#x000a0;to 1.5&#x000a0;g/kg.<xref ref-type="bibr" rid="article-90188.r4">[4]</xref> Hyperventilation after intubation and sedation to a pCO&#x000a0;of 28&#x000a0;to 32&#x000a0;mmHg will be necessary if ICP increases further. ASA recommends monitoring ICP with a parenchymal or ventricular catheter for all patients with Glasgow coma scale (GCS) &#x0003c;8 or those with evidence of transtentorial herniation or hydrocephalus.<xref ref-type="bibr" rid="article-90188.r20">[20]</xref> The ventricular catheter has the advantage of drainage of cerebrospinal fluid (CSF) in the case of hydrocephalus. The aim is to keep cerebral perfusion pressure (CPP) between 50 to 70mmHg.</p>
        <p>
<bold>Hemostatic Therapy</bold>
</p>
        <p>Hemostatic therapy is given to reduce the progression of hematoma.<xref ref-type="bibr" rid="article-90188.r4">[4]</xref> This is especially important to reverse the coagulopathy in patients taking anticoagulants. Vitamin K, prothrombin complex concentrates (PCCs), recombinant activated factor VII (rFVIIa), fresh frozen plasma (FFP), etc., are used.<xref ref-type="bibr" rid="article-90188.r4">[4]</xref><xref ref-type="bibr" rid="article-90188.r20">[20]</xref><xref ref-type="bibr" rid="article-90188.r4">[4]</xref>&#x000a0;ASA recommends that patients with thrombocytopenia should receive platelet concentrate.<xref ref-type="bibr" rid="article-90188.r20">[20]</xref> Patients with elevated prothrombin time INR should receive intravenous vitamin K and FFP or PCCs. FFP has the risk of allergic transfusion reactions. PCCs are plasma-derived factor concentrates containing factors II, VII, IX, and X. PCCs can be reconstituted and administered rapidly. The FAST trial showed that rFVIIa reduced the growth of the hematoma but did not improve survival or functional outcome.<xref ref-type="bibr" rid="article-90188.r26">[26]</xref>&#x000a0;rFVIIa is not recommended in unselected patients since it does not replace all clotting factors.<xref ref-type="bibr" rid="article-90188.r20">[20]</xref></p>
        <p>
<bold>Antiepileptic Therapy</bold>
</p>
        <p>Around 3&#x000a0;to 17% of patients will have a seizure in the first two weeks, and 30% of patients will show electrical seizure activity on EEG monitoring.<xref ref-type="bibr" rid="article-90188.r20">[20]</xref> Those with clinical seizures or electrographic seizures should be treated with antiepileptic drugs.&#x000a0;Lobar hematoma and the enlargement of hematoma produce seizures associated with neurological worsening. Subclinical seizures and non-convulsive status epileptics also can occur. <bold>C</bold>ontinuous EEG monitoring is indicated in patients with a decreased level of consciousness. Otherwise, prophylactic anticonvulsant medication is not recommended, according to ASA guidelines.<xref ref-type="bibr" rid="article-90188.r27">[27]</xref></p>
        <p>
<bold>Surgery</bold>
</p>
        <p>The different types of surgical treatment for hemorrhagic stroke are craniotomy, decompressive craniectomy, stereotactic aspiration, endoscopic aspiration, and catheter aspiration.<xref ref-type="bibr" rid="article-90188.r4">[4]</xref>&#x000a0;The STICH trial showed no overall benefit from early surgery for supratentorial intracerebral hemorrhage compared with initial conservative treatment.<xref ref-type="bibr" rid="article-90188.r28">[28]</xref> Those who have lobar hemorrhages within 1 cm of the surface of the brain and milder clinical deficits (GCS&#x0003e;9) may benefit from early surgery.&#x000a0;Emergency surgical evacuation is indicated in cerebellar hemorrhage with hydrocephalus or brainstem compression.[21] Patients with cerebellar hemorrhages of &#x0003e;3 cm in diameter will have better outcomes with surgery. Cerebellar hematoma is evacuated by suboccipital craniectomy. Evacuation of brainstem hemorrhages can be harmful and is not recommended. A minimally invasive procedure such as stereotactic aspiration is also on trial. Hattori et al. showed in a randomized study that stereotactic evacuation is of value in patients with spontaneous putaminal hemorrhage, whose eyes will open in response to strong stimuli.<xref ref-type="bibr" rid="article-90188.r29">[29]</xref></p>
        <p>Minimally invasive surgery plus recombinant tissue plasminogen activator(rt-PA) for Intracerebral Hemorrhage Evacuation (MISTIE) was a randomized, prospective trial that tested image-guided catheter-based removal of the blood clot.<xref ref-type="bibr" rid="article-90188.r30">[30]</xref> It showed a reduction in perihematomal edema with clot evacuation.</p>
        <p>The Clot Lysis: Evaluating Accelerated Resolution of IntraVentricularr Hemorrhage (CLEAR IVH) trial showed that low-dose rt-PA can be safely administered to stable intraventricular clots and can increase lysis rates.<xref ref-type="bibr" rid="article-90188.r31">[31]</xref> Decompressive craniectomy and hematoma evacuation are now being done more frequently for hemorrhagic stroke. Moussa and Khedr showed the improvement in outcome gained by adding decompressive craniectomy with expansive duraplasty to the evacuation of large hypertensive hemispheric ICH in a randomized controlled trial.<xref ref-type="bibr" rid="article-90188.r32">[32]</xref> Decompressive hemicraniectomy with hematoma evacuation is performed in patients with GCS scores of 8 or less and large hematomas with a volume greater than 60 ml (fig.5).<xref ref-type="bibr" rid="article-90188.r33">[33]</xref> It reduces mortality and may improve functional outcomes.</p>
        <p>
<bold>Cerebroprotection</bold>
</p>
        <p>The secondary injury of hemorrhagic stroke comprises inflammation, oxidative stress, and toxicity of erythrocyte lysates and thrombin. So, strategies to reduce these are being tried. Pioglitazone, misoprostol, and celecoxib are tried to reduce inflammatory damage. Edaravone, flavanoid, and nicotinamide mononucleotide can reduce oxidative stress. The iron chelator deferoxamine is also in the experimental phase. The safety and neuroprotective efficacy of the cell membrane component citicoline (cytidine-5-diphosphocholine) has been shown in some studies.<xref ref-type="bibr" rid="article-90188.r34">[34]</xref> Rosuvastatin, a competitive inhibitor of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase, was associated with a better outcome in a trial. The calcium channel blocker nimodipine improves outcomes in SAH by a neuroprotective effect.<xref ref-type="bibr" rid="article-90188.r35">[35]</xref><xref ref-type="bibr" rid="article-90188.r35">[35]</xref></p>
        <p>
<bold>General Care</bold>
</p>
        <p>Good medical care, nursing care, and rehabilitation are paramount.<xref ref-type="bibr" rid="article-90188.r20">[20]</xref>&#x000a0;Common problems include dysphagia, aspiration, cardiac arrhythmias, stress-induced cardiomyopathy, cardiac failure, acute kidney injury, gastrointestinal bleeding, urinary tract infection, etc. Percutaneous endoscopic gastrostomy (PEG) may be needed to prevent aspiration. Screening for myocardial ischemia with electrocardiogram and cardiac enzyme testing is recommended in hemorrhagic stroke. Intermittent pneumatic compression reduces the occurrence of deep vein thrombosis, but the usefulness of elastic stockings is doubtful.&#x000a0;Multidisciplinary rehabilitation is advised to reduce disability. Blood glucose should be monitored, and measures should be taken to prevent both hyperglycemia and hypoglycemia.<xref ref-type="bibr" rid="article-90188.r36">[36]</xref></p>
      </sec>
      <sec id="article-90188.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses of hemorrhagic stroke are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute hypertensive crisis</p>
          </list-item>
          <list-item>
            <p>Pituitary apoplexy</p>
          </list-item>
          <list-item>
            <p>Cerebral venous thrombosis</p>
          </list-item>
          <list-item>
            <p>Dural sinus thrombosis</p>
          </list-item>
          <list-item>
            <p>Cervical artery dissection</p>
          </list-item>
          <list-item>
            <p>Reversible cerebral vasoconstrictive syndrome (RCVS)</p>
          </list-item>
          <list-item>
            <p>Hemorrhagic neoplasms</p>
          </list-item>
          <list-item>
            <p>Arterio-venous malformations</p>
          </list-item>
          <list-item>
            <p>Meningitis</p>
          </list-item>
          <list-item>
            <p>Acute subdural hematoma</p>
          </list-item>
          <list-item>
            <p>Hemorrhagic infarct</p>
          </list-item>
        </list>
        <p>Imaging studies such as CT and MRI can rule out these entities.<xref ref-type="bibr" rid="article-90188.r37">[37]</xref></p>
      </sec>
      <sec id="article-90188.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The poor prognostic factors are coma, large hematoma with volume greater than 30 ml, intraventricular hemorrhage, posterior fossa hemorrhage, old age greater than 80 years, hyperglycemia, and chronic kidney disease.<xref ref-type="bibr" rid="article-90188.r5">[5]</xref> Early deterioration and death are the major problems with ICH. Coma, at the time of the presentation, indicates a grave prognosis. ASA recommends that the monitoring and management of patients with ICH should be in a dedicated stroke unit. At six months, only 20 percent of patients become independent. The survivors may enter into a persistent vegetative state or locked-in syndrome in case of extensive hemispherical damage or brainstem involvement, respectively.</p>
        <p>ICH score introduced by Hemphill et al. predicts mortality.<xref ref-type="bibr" rid="article-90188.r38">[38]</xref><xref ref-type="bibr" rid="article-90188.r39">[39]</xref>&#x000a0;The points are given as 2 points for Glasgow Coma Scale score (GCS) 3-4, 1 point for GCS 5-12, 0 points for GCS 13-15, 1 point for&#x0003e;80 years, 0 points for &#x0003c;80 years, 1 point for infratentorial location, 0 points for supratentorial location, 1 point for ICH volume &#x0003e;30 ml, 0 points for volume &#x0003c;30 ml. 1 point for intraventricular hemorrhage and 0 points for the absence of intraventricular hemorrhage. The 30-day mortality of each score is as: 0% for score 0, 13% for score 1, 26% for score 2, 72% for score 3, 97% for score 4, and 100% for scores 5&#x000a0;and 6.</p>
      </sec>
      <sec id="article-90188.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of ICH include cerebral edema, increased intracranial pressure, hydrocephalus, seizures, venous thrombotic events, hyperglycemia, increased blood pressure, fever, and infections.<xref ref-type="bibr" rid="article-90188.r40">[40]</xref>&#x000a0;Patients with ICH, especially women, have a risk of thromboembolic disease.<xref ref-type="bibr" rid="article-90188.r20">[20]</xref> Almost one-third of patients with ICH develop pulmonary complications such as pneumonia, aspiration, pulmonary edema, respiratory failure, and respiratory distress. About 4% of patients with ICH suffer cardiac complications such as myocardial infarction, atrial fibrillation, ventricular fibrillation, ventricular tachycardia, stress-induced cardiomyopathy, and acute heart failure.<xref ref-type="bibr" rid="article-90188.r41">[41]</xref></p>
        <p>Vasospasm, ischemia, rebleeding, seizure, hyponatremia, and hydrocephalus are the complications of SAH. Neurogenic pulmonary edema, an increase in interstitial and alveolar fluid, commonly occurs in subarachnoid hemorrhage.<xref ref-type="bibr" rid="article-90188.r42">[42]</xref></p>
      </sec>
      <sec id="article-90188.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>There is a chance of recurrence of ICH. Hypertension and old age are risk factors. BP should be controlled. Lifestyle modifications should be advised,&#x000a0;including avoidance of alcohol, tobacco, and illicit drugs. Continued multidisciplinary rehabilitation should be done.</p>
        <p>The following are the possible risk factors for a recurrent ICH:</p>
        <list list-type="bullet">
          <list-item>
            <p>Lobar location of the initial&#x000a0;ICH</p>
          </list-item>
          <list-item>
            <p>Older age</p>
          </list-item>
          <list-item>
            <p>Presence and number of microbleeds on gradient echo MRI</p>
          </list-item>
          <list-item>
            <p>Ongoing anticoagulation</p>
          </list-item>
          <list-item>
            <p>Presence of apolipoprotein E epsilon 2 or epsilon 4 alleles<xref ref-type="bibr" rid="article-90188.r20">[20]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-90188.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients with&#x000a0;hemorrhagic stroke should be managed in a dedicated&#x000a0;stroke unit with emergency and critical care, neurology and neurosurgery, and neuroradiology for the best outcome.&#x000a0;The intensivists, physicians, and critical care nurses should be well versed in emergency neurological life support (ENLS). This&#x000a0;is especially necessary in low- and middle-income countries. The surgical methods should be done and assessed in a standardized manner. More trials are needed to confirm the role and usefulness of surgical interventions. Cognitive rehabilitation therapy (CRT) also should be given to the survivors.</p>
      </sec>
      <sec id="article-90188.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=90188&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=90188">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/stroke/hemorrhagic-stroke/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=90188">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/90188/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=90188">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-90188.s15">
        <fig id="article-90188.image.f1" position="float" orientation="portrait">
          <caption>
            <p>The illustration shows how a hemorrhagic stroke can occur in the brain. An aneurysm in a cerebral artery breaks open, which causes bleeding in the brain. The pressure of the blood causes brain tissue death. Contributed by National Heart Lung and Blood Institute (NIH)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Stroke_hemorrhagic" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-90188.s16">
        <fig id="article-90188.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Fig.1. CT scan of lobar hemorrhage Owned by Dr. Ajaya Kumar A.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ICH" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-90188.s17">
        <fig id="article-90188.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Fig.2. CT scan of pontine hemorrhage. Owned by Dr. Ajaya Kumar A.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Pontine__bleed" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-90188.s18">
        <fig id="article-90188.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Fig.3. CT scan of cerebellar hemorrhage. Owned by Dr. Ajaya Kumar A.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cerebellar__bleed" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-90188.s19">
        <fig id="article-90188.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Fig.4. CT Angiogram of a patient with ICH Owned by Dr. Ajaya Kumar A.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CTA" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-90188.s20">
        <title>References</title>
        <ref id="article-90188.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Progressing haemorrhagic stroke: categories, causes, mechanisms and managements.</article-title>
            <source>J Neurol</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>261</volume>
            <issue>11</issue>
            <fpage>2061</fpage>
            <page-range>2061-78</page-range>
            <pub-id pub-id-type="pmid">24595959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitagawa</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Blood pressure management for secondary stroke prevention.</article-title>
            <source>Hypertens Res</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>936</fpage>
            <page-range>936-943</page-range>
            <pub-id pub-id-type="pmid">35437312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castello</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Pasi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kubiszewski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Abramson</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Charidimou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kourkoulis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>DiPucchio</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Schwab</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Gurol</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Rosand</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Viswanathan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Biffi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cerebral Small Vessel Disease and Depression Among Intracerebral Hemorrhage Survivors.</article-title>
            <source>Stroke</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>53</volume>
            <issue>2</issue>
            <fpage>523</fpage>
            <page-range>523-531</page-range>
            <pub-id pub-id-type="pmid">34587793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ojaghihaghighi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vahdati</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Mikaeilpour</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ramouz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Comparison of neurological clinical manifestation in patients with hemorrhagic and ischemic stroke.</article-title>
            <source>World J Emerg Med</source>
            <year>2017</year>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-38</page-range>
            <pub-id pub-id-type="pmid">28123618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>An</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update.</article-title>
            <source>J Stroke</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-10</page-range>
            <pub-id pub-id-type="pmid">28178408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magid-Bernstein</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Girard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Polster</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Srinath</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Romanos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Sansing</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions.</article-title>
            <source>Circ Res</source>
            <year>2022</year>
            <month>Apr</month>
            <day>15</day>
            <volume>130</volume>
            <issue>8</issue>
            <fpage>1204</fpage>
            <page-range>1204-1229</page-range>
            <pub-id pub-id-type="pmid">35420918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aronowski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Molecular pathophysiology of cerebral hemorrhage: secondary brain injury.</article-title>
            <source>Stroke</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>1781</fpage>
            <page-range>1781-6</page-range>
            <pub-id pub-id-type="pmid">21527759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsuyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okuchi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Seki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Higuchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Murao</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Perimesencephalic nonaneurysmal subarachnoid hemorrhage caused by physical exertion.</article-title>
            <source>Neurol Med Chir (Tokyo)</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>277</fpage>
            <page-range>277-81; discussion 281-2</page-range>
            <pub-id pub-id-type="pmid">16794347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coelho</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>EI</given-names>
              </name>
            </person-group>
            <article-title>Non-aneurysmal spontaneous subarachnoid hemorrhage: perimesencephalic versus non-perimesencephalic.</article-title>
            <source>Rev Bras Ter Intensiva</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>141</fpage>
            <page-range>141-6</page-range>
            <pub-id pub-id-type="pmid">27410409</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fekadu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chelkeba</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kebede</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Risk factors, clinical presentations and predictors of stroke among adult patients admitted to stroke unit of Jimma university medical center, south west Ethiopia: prospective observational study.</article-title>
            <source>BMC Neurol</source>
            <year>2019</year>
            <month>Aug</month>
            <day>07</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>187</fpage>
            <pub-id pub-id-type="pmid">31390995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kushner</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bressman</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>The clinical manifestations of pontine hemorrhage.</article-title>
            <source>Neurology</source>
            <year>1985</year>
            <month>May</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>637</fpage>
            <page-range>637-43</page-range>
            <pub-id pub-id-type="pmid">3990963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hakimi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Imaging of Hemorrhagic Stroke.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>22</volume>
            <issue>5, Neuroimaging</issue>
            <fpage>1424</fpage>
            <page-range>1424-1450</page-range>
            <pub-id pub-id-type="pmid">27740983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Rosand</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Hemorrhagic stroke.</article-title>
            <source>Neuroimaging Clin N Am</source>
            <year>2005</year>
            <month>May</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>259</fpage>
            <page-range>259-72, ix</page-range>
            <pub-id pub-id-type="pmid">16198939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kazui</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Minematsu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sawada</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Predisposing factors to enlargement of spontaneous intracerebral hematoma.</article-title>
            <source>Stroke</source>
            <year>1997</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>12</issue>
            <fpage>2370</fpage>
            <page-range>2370-5</page-range>
            <pub-id pub-id-type="pmid">9412616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Broderick</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Brott</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Duldner</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Tomsick</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Huster</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality.</article-title>
            <source>Stroke</source>
            <year>1993</year>
            <month>Jul</month>
            <volume>24</volume>
            <issue>7</issue>
            <fpage>987</fpage>
            <page-range>987-93</page-range>
            <pub-id pub-id-type="pmid">8322400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Macellari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Paciaroni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Agnelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Caso</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Neuroimaging in intracerebral hemorrhage.</article-title>
            <source>Stroke</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>903</fpage>
            <page-range>903-8</page-range>
            <pub-id pub-id-type="pmid">24425128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Baxter</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Bybee</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Tirschwell</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Abouelsaad</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage.</article-title>
            <source>Stroke</source>
            <year>1999</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>10</issue>
            <fpage>2025</fpage>
            <page-range>2025-32</page-range>
            <pub-id pub-id-type="pmid">10512902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delgado Almandoz</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Advanced CT imaging in the evaluation of hemorrhagic stroke.</article-title>
            <source>Neuroimaging Clin N Am</source>
            <year>2011</year>
            <month>May</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>197</fpage>
            <page-range>197-213, ix</page-range>
            <pub-id pub-id-type="pmid">21640295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siddiqui</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Bekker</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Qureshi</surname>
                <given-names>AI</given-names>
              </name>
            </person-group>
            <article-title>Neuroimaging of hemorrhage and vascular defects.</article-title>
            <source>Neurotherapeutics</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>28</fpage>
            <page-range>28-38</page-range>
            <pub-id pub-id-type="pmid">21274683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hemphill</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bendok</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Cushman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fung</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Macdonald</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Selim</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>D</given-names>
              </name>
              <collab>American Heart Association Stroke Council</collab>
              <collab>Council on Cardiovascular and Stroke Nursing</collab>
              <collab>Council on Clinical Cardiology</collab>
            </person-group>
            <article-title>Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.</article-title>
            <source>Stroke</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>46</volume>
            <issue>7</issue>
            <fpage>2032</fpage>
            <page-range>2032-60</page-range>
            <pub-id pub-id-type="pmid">26022637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schlunk</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kuthe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Harmel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Audebert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hanning</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Bohner</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Scheel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kleine</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nawabi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Volumetric accuracy of different imaging modalities in acute intracerebral hemorrhage.</article-title>
            <source>BMC Med Imaging</source>
            <year>2022</year>
            <month>Jan</month>
            <day>15</day>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <pub-id pub-id-type="pmid">35033012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berlit</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of cerebral vasculitis.</article-title>
            <source>Ther Adv Neurol Disord</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-42</page-range>
            <pub-id pub-id-type="pmid">21180634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lapchak</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Araujo</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Advances in hemorrhagic stroke therapy: conventional and novel approaches.</article-title>
            <source>Expert Opin Emerg Drugs</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>389</fpage>
            <page-range>389-406</page-range>
            <pub-id pub-id-type="pmid">17874968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qureshi</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Palesch</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Novitzke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cruz-Flores</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ehtisham</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ezzeddine</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Hussein</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Suri</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Tariq</surname>
                <given-names>N</given-names>
              </name>
              <collab>Antihypertensive Treatment of Acute Cerebral Hemorrhage Study Investigators</collab>
            </person-group>
            <article-title>Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study.</article-title>
            <source>Arch Neurol</source>
            <year>2010</year>
            <month>May</month>
            <volume>67</volume>
            <issue>5</issue>
            <fpage>570</fpage>
            <page-range>570-6</page-range>
            <pub-id pub-id-type="pmid">20457956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Arima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Heeley</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Skulina</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Parsons</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tao</surname>
                <given-names>QL</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Tai</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Morgenstern</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Chalmers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JG</given-names>
              </name>
              <collab>INTERACT Investigators</collab>
            </person-group>
            <article-title>Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT).</article-title>
            <source>Stroke</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>307</fpage>
            <page-range>307-12</page-range>
            <pub-id pub-id-type="pmid">20044534</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mayer</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Brun</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Begtrup</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Broderick</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Diringer</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Skolnick</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Steiner</surname>
                <given-names>T</given-names>
              </name>
              <collab>FAST Trial Investigators</collab>
            </person-group>
            <article-title>Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.</article-title>
            <source>N Engl J Med</source>
            <year>2008</year>
            <month>May</month>
            <day>15</day>
            <volume>358</volume>
            <issue>20</issue>
            <fpage>2127</fpage>
            <page-range>2127-37</page-range>
            <pub-id pub-id-type="pmid">18480205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gigliotti</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Srikanth</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cockroft</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Patterns of prophylactic anticonvulsant use in spontaneous intracerebral and subarachnoid hemorrhage: results of a practitioner survey.</article-title>
            <source>Neurol Sci</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>1873</fpage>
            <page-range>1873-1877</page-range>
            <pub-id pub-id-type="pmid">34495437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendelow</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Gregson</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Teasdale</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Hope</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Karimi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Barer</surname>
                <given-names>DH</given-names>
              </name>
              <collab>STICH investigators</collab>
            </person-group>
            <article-title>Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial.</article-title>
            <source>Lancet</source>
            <string-date>2005 Jan 29-Feb 4</string-date>
            <volume>365</volume>
            <issue>9457</issue>
            <fpage>387</fpage>
            <page-range>387-97</page-range>
            <pub-id pub-id-type="pmid">15680453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hattori</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Katayama</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Maya</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gatherer</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Impact of stereotactic hematoma evacuation on activities of daily living during the chronic period following spontaneous putaminal hemorrhage: a randomized study.</article-title>
            <source>J Neurosurg</source>
            <year>2004</year>
            <month>Sep</month>
            <volume>101</volume>
            <issue>3</issue>
            <fpage>417</fpage>
            <page-range>417-20</page-range>
            <pub-id pub-id-type="pmid">15352598</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mould</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Carhuapoma</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Muschelli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>McBee</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Bistran-Hall</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Ullman</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Vespa</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zuccarello</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanley</surname>
                <given-names>DF</given-names>
              </name>
              <collab>MISTIE Investigators</collab>
            </person-group>
            <article-title>Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema.</article-title>
            <source>Stroke</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>627</fpage>
            <page-range>627-34</page-range>
            <pub-id pub-id-type="pmid">23391763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morgan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Keyl</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hanley</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial.</article-title>
            <source>Acta Neurochir Suppl</source>
            <year>2008</year>
            <volume>105</volume>
            <fpage>217</fpage>
            <page-range>217-20</page-range>
            <pub-id pub-id-type="pmid">19066112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moussa</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Khedr</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Decompressive craniectomy and expansive duraplasty with evacuation of hypertensive intracerebral hematoma, a randomized controlled trial.</article-title>
            <source>Neurosurg Rev</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>115</fpage>
            <page-range>115-127</page-range>
            <pub-id pub-id-type="pmid">27235128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takeuchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nagatani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Otani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Decompressive hemicraniectomy for spontaneous intracerebral hemorrhage.</article-title>
            <source>Neurosurg Focus</source>
            <year>2013</year>
            <month>May</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>E5</fpage>
            <pub-id pub-id-type="pmid">23634924</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kellner</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Neuroprotective strategies for intracerebral hemorrhage: trials and translation.</article-title>
            <source>Stroke</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>41</volume>
            <issue>10 Suppl</issue>
            <fpage>S99</fpage>
            <page-range>S99-102</page-range>
            <pub-id pub-id-type="pmid">20876519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laskowitz</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Kolls</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Neuroprotection in subarachnoid hemorrhage.</article-title>
            <source>Stroke</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>41</volume>
            <issue>10 Suppl</issue>
            <fpage>S79</fpage>
            <page-range>S79-84</page-range>
            <pub-id pub-id-type="pmid">20876512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Acute glycemic variability and mortality of patients with acute stroke: a meta-analysis.</article-title>
            <source>Diabetol Metab Syndr</source>
            <year>2022</year>
            <month>May</month>
            <day>10</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <pub-id pub-id-type="pmid">35538585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Linn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Br&#x000fc;ckmann</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Differential diagnosis of nontraumatic intracerebral hemorrhage.</article-title>
            <source>Klin Neuroradiol</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-61</page-range>
            <pub-id pub-id-type="pmid">19636678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hemphill</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Bonovich</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Besmertis</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Manley</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>The ICH score: a simple, reliable grading scale for intracerebral hemorrhage.</article-title>
            <source>Stroke</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>891</fpage>
            <page-range>891-7</page-range>
            <pub-id pub-id-type="pmid">11283388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trevisi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Caccavella</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Scerrati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Signorelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Salamone</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Orsini</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fasciani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>D'Arrigo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Auricchio</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>D'Onofrio</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Salomi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Albanese</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Bonis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mangiola</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sturiale</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Machine learning model prediction of 6-month functional outcome in elderly patients with intracerebral hemorrhage.</article-title>
            <source>Neurosurg Rev</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>45</volume>
            <issue>4</issue>
            <fpage>2857</fpage>
            <page-range>2857-2867</page-range>
            <pub-id pub-id-type="pmid">35522333</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balami</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Buchan</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Complications of intracerebral haemorrhage.</article-title>
            <source>Lancet Neurol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <page-range>101-18</page-range>
            <pub-id pub-id-type="pmid">22172625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Putaala</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lehto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Meretoja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Silvennoinen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Curtze</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>K&#x000e4;&#x000e4;ri&#x000e4;inen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Koivunen</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Kaste</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tatlisumak</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Strbian</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>In-hospital cardiac complications after intracerebral hemorrhage.</article-title>
            <source>Int J Stroke</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>741</fpage>
            <page-range>741-6</page-range>
            <pub-id pub-id-type="pmid">24025067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-90188.r42">
          <label>42</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Al-Dhahir</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Neurogenic Pulmonary Edema</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">30422579</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
